Drugs / TIV
last change May 2010 re-read 3 minutes ago

TIV

Vaccine

Developed for
influenza

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 2 NCT01014806 Comparator Nov 2009 → May 2010 influenza Novavax Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT01014806 ↗
Modality Vaccine “Trivalent Influenza Vaccine” NCT01014806 ↗